Breathing might seem simple, but when it goes wrong, it can quietly disrupt your entire life. Dysfunctional breathing (DB) is far more common than most people realize—and the surprising part is how often it’s misdiagnosed or poorly managed. The result? People end up struggling with fatigue, anxiety, or unexplained shortness of breath—often without knowing the real cause. But here’s where it gets even more complex: tobacco use and underlying respiratory diseases can significantly worsen the condition—and that’s something researchers are now digging into.
A research team from Osaka Metropolitan University set out to uncover the bigger picture behind DB. Their goal was to determine how widespread this issue is, what clinical features define it, and what factors—especially tobacco use—are linked to its prevalence. They also wanted to explore how smoking and respiratory illnesses might interact to raise the risk of DB.
To do this, the team carried out a large Internet-based cross-sectional survey involving 29,268 participants drawn from the general Japanese population. They used the Nijmegen Questionnaire (NQ), a highly regarded diagnostic tool known for its precise identification of DB. The survey revealed that about 11 percent of participants met the criteria for dysfunctional breathing. That’s one in every nine people—an unexpectedly high figure.
When the researchers looked closer through univariable logistic analysis, they found clear connections between DB and several respiratory conditions—particularly asthma, chronic obstructive pulmonary disease (COPD), and histories of bronchitis or pneumonia. Interestingly, even some non-respiratory health issues, such as epilepsy and cerebrovascular disease, were found to have significant associations with dysfunctional breathing. But that’s not the end of the story. The multivariate analysis showed something even more striking: individuals who currently smoked, especially those with respiratory diseases, had a markedly higher likelihood of developing DB.
These results paint a clear picture. Dysfunctional breathing isn’t just confined to those with diagnosed lung diseases—it’s also affecting the broader population, often going unnoticed in primary healthcare settings. Tobacco use, in particular, seems to amplify the risk, acting as a key trigger in people already dealing with respiratory comorbidities. Recognizing and managing these risk factors could dramatically improve patients’ well-being and reduce unnecessary medical interventions.
So the question becomes: if dysfunctional breathing is this widespread and influenced by everyday habits like smoking, should healthcare systems start screening for it more actively? And what role should tobacco control play in improving respiratory health beyond its already-known risks? The debate is far from over—what do you think?
